The global Radiopharmaceuticals Market is experiencing robust momentum, with new projections estimating its value will surge from USD 5.0 billion in 2023 to an impressive USD 16.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.4% during the forecast period from 2024 to 2032. The accelerated adoption of nuclear medicine, expanding applications in oncology and cardiology,...